Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corporation (TSX:WEED) (NASDAQ: CGC) is scheduled to release its financial results for the second quarter fiscal year 2022 ended September 30, 2021, before financial markets open on November 5, 2021.  On Wednesday, the Canadian cannabis giant announced the launch of two new product offerings from its Deep Space brand – Limon Splashdown and Deep Space XPRESS, while last week it confirmed the launch of a new CBD line – Harvest Medley CBD Wellness Gummies in partnership with Martha Stewart and Marquee Brands.

What Can Help Canopy Growth Reach $250M In Sales? Analyst's Thoughts Ahead Of Earnings

Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced Wednesday the launch of two new product offerings from its Deep Space brand – Limon Splashdown and Deep Space XPRESS. Limon Splashdown, the new 10mg THC-infused lemon-lime beverage is an addition to the brand's original cola flavor, while Deep Space XPRESS is the company's first single 10mg THC gummy offering in Canada.

Canopy Growth Launches First Single 10mg THC Gummy In Canada & Lemon-Lime THC Beverage

Cannabis Growth ETF

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Green Flower, founded by CEO Max Simon in 2014, is a training platform built for cannabis professionals. Ganjier is its cannabis sommelier certification program.

Standardizing Cannabis Operating Procedure (Podcast)

Aurora Cannabis

Cronos Group

Tilray Brands

JPMorgan Chase & Co has told prime brokerage clients it will no longer let them buy U.S. cannabis-related securities beginning Nov. 8, according to a letter seen by Reuters.

Exclusive-JPMorgan to restrict trading of U.S. cannabis stocks -letter

Constellation Brands

More research is needed on marijuana in the country, and the Medical Marijuana Research Act could make it easier for scientists to study the drug.

Could This Be the First Big Step Towards Marijuana Legalization?

SNDL Inc.

Wall Street predicts mergers and acquisitions, while Italy takes a step toward legalization.

Why Canopy Growth, Aurora Cannabis, Tilray, and Sundial Stocks Are on Fire

Village Farms International

Best Marijuana Stocks To Buy In Q4 2021 As top marijuana stocks… The post Top Canadian Cannabis Stocks To Buy In November? 4 To Add To Your List Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks To Buy In November? 4 To Add To Your List Right Now

With the U.S. cannabis market booming, are domestic players the better option?

Better Marijuana Stock: Cresco Labs vs. Canopy Growth

Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: Should You Buy?

Agrify

Turning Point Brands

Valley National

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

Cannabis Stocks in Focus This week

In the latest trading session, Canopy Growth Corporation (CGC) closed at $13.01, marking a +1.76% move from the previous day.

Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know

Abbott Labs

Boston Scientific

Quest Diagnostics

Henry Schein

IDEXX Laboratories

Insulet

Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.

4 Medical Products Stocks Poised to Beat This Earnings Season

New Harvest Medley Gummies, Mini CBD Peppermint Ribbons and Snowflake CBD Gummy Sampler Arrive Just in Time for the Holiday Season ­­SMITHS FALLS, ON and NEW YORK, Oct. 28, 2021 /PRNewswire/ - Today, Martha Stewart CBD unveiled the latest innovations in its CBD portfolio - Harvest Medley CBD Wellness Gummies, which will exist as a permanent offering, and the limited-edition Mini CBD Peppermint Ribbons and Snowflake CBD Gummy Sampler, available exclusively during the holiday season. Each new offering is perfect to help people prioritize their mental wellbeing, especially for those looking to give the gift of wellness through the holidays and beyond.

Martha Stewart CBD Unveils New Fall Flavors and Limited-Edition Holiday Products, Expanding Portfolio of Best-In-Class CBD Wellness Offerings

The company has multiple deals in place that would give it a significant footprint in the U.S. pot market -- once it is fully legal.

Canopy Growth Announces Yet Another U.S. Acquisition

Canaccord Genuity Corp released its cannabis market report indicating a 26% increase in revenue opportunities for US businesses, reaching up to $30 billion in revenue in 2022. The report also outlines a compelling value proposition for Multi-State-Operators (MSOs) even though cannabis equities continue to face headwinds despite positive fundamental performances.

Canaccord Genuity predicts 26% revenue increase for US cannabis market in 2022, says revenue likely to cross $30B

Is Canopy Growth Stock A Buy Or Sell Now? Why I'm Getting Bullish

The company expects to be profitable by the end of its current fiscal year, but analysts aren't convinced.

Analysts Are Losing Hope in Canopy Growth. Should Investors Ditch the Stock?

Evogene

Flora Growth Corp

Greenlane Holdings

HEXO Corp

High Tide

See Why a Slew of Pot Stocks Made the News This Week

Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.

Insider Cannabis: Time to buy US cannabis stocks - New York's legal gray area - Deals, deals, deals

OrganiGram Holdings Inc.

Are Canadian Pot Stocks Ready To Rebound In Q4 2021? The post Top Canadian Cannabis Stocks To Buy Now? 2 LPs For Watchlist Today appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks To Buy Now? 2 LPs For Watchlist Today

SMITHS FALLS, ON, Oct. 22, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2022 ended September 30, 2021, before financial markets open on November 5, 2021. Following the release of its second quarter fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Mike Lee, EVP & CFO at 10:00 AM Eastern Time on November 5, 2021.

Canopy Growth to Report Q2 2022 Financial Results on November 5, 2021

Why Canopy Growth, Tilray, and Hexo Stocks Dropped

Canopy Growth Corporation (CGC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Canopy Growth Corporation (CGC) Moves 8.6% Higher: Will This Strength Last?

New York and California have both ruled in favor of pro-cannabis policies. The future is looking green for cannabis stocks.

Cannabis Stocks: Why CGC, TLRY, SNDL, CRON Stocks Are Getting High Today

Canopy Growth Corp. (NASDAQ:CGC) shares are trading higher Tuesday along with other cannabis stocks. Canopy Growth closed up 8.6% at $14.34.

Canopy Growth Looks Like It's Ready To Break Out And Change Directions

News for Canopy Growth Stock (CGC)